Related references
Note: Only part of the references are listed.Efficacy of membrane TNF mediated host resistance is dependent on mycobacterial virulence
I. Dambuza et al.
TUBERCULOSIS (2008)
Effect of TNF antagonists on the T-lymphocyte response
Dominique Emilie
JOINT BONE SPINE (2007)
T helper 2 Cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis
James Harris et al.
IMMUNITY (2007)
Neutralization of tumor necrosis factor (TNF) by antibody but not TNF receptor fusion molecule exacerbates chronic murine tuberculosis
Hillarie L. Plessner et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Tumor necrosis factor is critical to control tuberculosis infection
Muazzam Jacobs et al.
MICROBES AND INFECTION (2007)
Risk and prevention of tuberculosis and other serious opportunistic infections associated with the inhibition of tumor necrosis factor
Kevin L. Winthrop
NATURE CLINICAL PRACTICE RHEUMATOLOGY (2006)
Transmembrane TNF protects mutant mice against intracellular bacterial infections, chronic inflammation and autoimmunity
Lena Alexopoulou et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2006)
Tumor-necrosis-factor blockers: Differential effects on mycobacterial immunity
Oluwabunmi Y. Saliu et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism
V Deretic et al.
CELLULAR MICROBIOLOGY (2006)
A vitellogenic-like carboxypeptidase expressed by human macrophages is localized in endoplasmic reticulum and membrane ruffles
J Harris et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2006)
Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists
Haifa Hamdi et al.
ARTHRITIS RESEARCH & THERAPY (2006)
TNF-blocking agents and tuberculosis: new drugs illuminate an old topic
J Keane
RHEUMATOLOGY (2005)
Update on the British Society for Rheumatology guidelines for prescribing TNFα blockers in adults with rheumatoid arthritis (update of previous guidelines of April 2001)
J Ledingham et al.
RHEUMATOLOGY (2005)
Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages
MG Gutierrez et al.
CELL (2004)
Granulomatous infections due to tumor necrosis factor blockade: Correction
RS Wallis et al.
CLINICAL INFECTIOUS DISEASES (2004)
Immune control of tuberculosis by IFN-γ-inducible LRG-47
JD MacMicking et al.
SCIENCE (2003)
Potential of tumor necrosis factor neutralization strategies in rheumatologic disorders other than rheumatoid arthritis
DG Stokes et al.
SEMINARS IN ARTHRITIS AND RHEUMATISM (2003)
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk -: A multicenter active-surveillance report
JJ Gómez-Reino et al.
ARTHRITIS AND RHEUMATISM (2003)
Salmonella septicemia in rheumatoid arthritis patients receiving anti-tumor necrosis factor therapy -: Association with decreased interferon-γ production and toll-like receptor 4 expression
MG Netea et al.
ARTHRITIS AND RHEUMATISM (2003)
Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor α-neutralizing agents
NR Slifman et al.
ARTHRITIS AND RHEUMATISM (2003)
Binding and functional comparisons of two types of tumor necrosis factor antagonists
B Scallon et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2002)
Tuberculosis associated with infliximab, a tumor necrosis factor (alpha)-neutralizing agent
J Keane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Infliximab downregulates interferon-γ production in activated gut T-lymphocytes from patients with Crohn's disease
J Agnholt et al.
CYTOKINE (2001)
Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
VP Mohan et al.
INFECTION AND IMMUNITY (2001)
Pentoxifylline treatment of mice with chronic pulmonary tuberculosis accelerates the development of destructive pathology
J Turner et al.
IMMUNOLOGY (2001)
Share Paper
